ORKA
Oruka Therapeutics, Inc.
Stock
$84.52+1.10 (+1.32%)Close Oct 2, 2026
- Capital expenditures, 2025
- $209K
- 5-year CAGR
- +61.5%
- 10-year CAGR
- +34.2%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $209K | — |
| 2023 | $0 | −100.0% |
| 2022 | $2K | −95.3% |
| 2021 | $43K | +126.3% |
| 2020 | $19K | +375.0% |
| 2019 | $4K | 0.0% |
| 2018 | $4K | +33.3% |
| 2017 | $3K | −75.0% |
| 2016 | $12K | +9.1% |
| 2015 | $11K | −42.1% |
| 2014 | $19K | −40.6% |
| 2013 | $32K | — |
| 2011 | $19K | +375.0% |
| 2010 | $4K | — |